University of Cincinnati

New growth factor protein helps damaged hearts

Published in Cardiovascular Device Liability Week, April 25th, 2004

Three patients at the University of Cincinnati (UC) and The University Hospital have grown new coronary arteries to increase blood flow to the heart after receiving a new growth factor protein (FGF1) in November 2003.

All three patients showed improved blood flow to the heart 3 months following the injection.

UC heart and vascular physicians were the first in the U.S. to inject this protein in heart patients in an attempt to grow new coronary arteries, according to UC officials. The procedure is part of a phase I clinical trial. This study measures the safety and effectiveness of FGF1 to grow new arteries, termed angiogenesis, in patients with angina...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Device Liability Week

Source: Cardiovascular Device Liability Week (2004-04-25)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry